Literature DB >> 8396034

Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications.

H E Dijkema1, E H Weil, P T Mijs, R A Janknegt.   

Abstract

Neuromodulation of sacral nerves is a new form of treatment for patients with refractory voiding dysfunctions such as incontinence, retention and chronic pelvic pain. Electrical stimulation of S3 activates the pelvic floor and modulates innervation of the bladder, sphincter and pelvic floor, restoring the balance and coordination in sacral reflexes. 19 of 23 patients with an implanted neuroprosthesis for neuromodulation have a more than 50% improvement in their main symptoms after a median follow-up of 12 months. In urge-incontinent patients the number of leakings decreased from 7.4 to 1.5/day, and the functional capacity increased from 135 to 227 ml.

Entities:  

Mesh:

Year:  1993        PMID: 8396034     DOI: 10.1159/000474266

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  14 in total

1.  [Sacral neuromodulation in treatment of functional disorders of the lower urinary tract. An overview of basic principles, indications, outcomes].

Authors:  A Bannowsky; C Seif; S Sugimoto; G Böhler; C van der Horst; S Bross; P Alken; K-P Jünemann; P M Braun
Journal:  Urologe A       Date:  2003-04-04       Impact factor: 0.639

Review 2.  A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction.

Authors:  Ash K Monga; Michael R Tracey; Jeyakumar Subbaroyan
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

3.  Sacral nerve stimulation for the management of voiding dysfunction.

Authors:  A K Das; M D White; P A Longhurst
Journal:  Rev Urol       Date:  2000

4.  Optimizing electrode implantation in sacral nerve stimulation--an anatomical cadaver study controlled by a laparoscopic camera.

Authors:  N C Buchs; J-C Dembe; J Robert-Yap; B Roche; J Fasel
Journal:  Int J Colorectal Dis       Date:  2007-08-18       Impact factor: 2.571

5.  Disorders of micturition in neurological patients. A clinical study of 786 patients.

Authors:  B Ventimiglia; F Patti; E Reggio; G Failla; C Morana; M Lopes; F Savoca; C Consoli; A Reggio
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

6.  Adverse events of sacral neuromodulation for fecal incontinence reported to the federal drug administration.

Authors:  Klaus Bielefeldt
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

7.  Percutaneous nerve evaluation based on electrode placement under control of autonomic innervation.

Authors:  W Kneist; D W Kauff; M Schröder; K P Koch; H Lang
Journal:  Tech Coloproctol       Date:  2014-05-27       Impact factor: 3.781

8.  A modified approach to patient's selection with improved clinical outcomes in sacral nerve modulation.

Authors:  Patrick Richard; Maude Carmel; Bechir Hage; Sophie Ramsay; Le Mai Tu
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

9.  Differences in sacral neuromodulation device infection rates based on preoperative antibiotic selection.

Authors:  Allen M Haraway; J Quentin Clemens; Chang He; Cynthia Stroup; Humphrey O Atiemo; Anne P Cameron
Journal:  Int Urogynecol J       Date:  2013-05-22       Impact factor: 2.894

Review 10.  Current and future trends in spinal cord stimulation for chronic pain.

Authors:  T R Deer
Journal:  Curr Pain Headache Rep       Date:  2001-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.